Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCZ3301 is a novel aryl-guanidino inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 449.00 | |
10 mg | In stock | $ 659.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,390.00 | |
100 mg | In stock | $ 1,880.00 | |
500 mg | In stock | $ 3,780.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 519.00 |
Description | DCZ3301 is a novel aryl-guanidino inhibitor. |
In vitro | Jurkat and HUT78 cells was markedly inhibited by DCZ3301 treatment in a time- and dose- dependent manner, IC50 values for Jurkat and HUT78 cells were 3.02 μM and 9.42 μM, respectively, after DCZ3301 treatment for 48 h. |
Synonyms | NPS ALX Compound 4a hydrochloride(1:1)(299433-10-6 Free base) |
Molecular Weight | 464.83 |
Formula | C20H16ClF3N6O2 |
CAS No. | 2136278-38-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (107.57 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DCZ3301 2136278-38-9 Others DCZ 3301 DCZ-3301 NPS ALX Compound 4a hydrochloride(1:1)(299433-10-6 Free base) inhibitor inhibit